FDA Gets it Right as Merck Suspends Sales of Cholesterol Drug Tredaptive

, Deputy director, Center for Science & Democracy

The drug company Merck is suspending sales of its cholesterol drug Tredaptive and asking doctors not to prescribe it due to the drug’s ineffectiveness and some non-fatal side effects. What’s most interesting here to me is that U.S. consumers have nothing to fear: the drug was available in the European Union, but not here.  FDA scientists rejected it in 2008. Read more >

Bookmark and Share